TrialInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022

Pembrolizumab in combination with tocilizumab in high-risk hospitalized patients with COVID-19 (COPERNICO): A randomized proof-of-concept phase II study.

Matilde Sánchez-Conde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.